ALERE I INFLUENZA A & B

Respiratory Virus Panel Nucleic Acid Assay System

ALERE SCARBOROUGH, INC D/B/A BINAX, INC.

The following data is part of a premarket notification filed by Alere Scarborough, Inc D/b/a Binax, Inc. with the FDA for Alere I Influenza A & B.

Pre-market Notification Details

Device IDK141520
510k NumberK141520
Device Name:ALERE I INFLUENZA A & B
ClassificationRespiratory Virus Panel Nucleic Acid Assay System
Applicant ALERE SCARBOROUGH, INC D/B/A BINAX, INC. 10 Southgate Rd Scarborough,  ME  04074
ContactAngela Drysdale
CorrespondentAngela Drysdale
ALERE SCARBOROUGH, INC D/B/A BINAX, INC. 10 Southgate Rd Scarborough,  ME  04074
Product CodeOCC  
Subsequent Product CodeOOI
Subsequent Product CodeOZE
CFR Regulation Number866.3980 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-06-09
Decision Date2014-06-13
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10811877010811 K141520 000
10811877010804 K141520 000
00811877010838 K141520 000
00811877010821 K141520 000
00811877010616 K141520 000
00811877010593 K141520 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.